Samsara BioCapital’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Samsara BioCapital’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-304,715	Closed	-$4.44M	–	57
2023 Q1	$4.44M	Hold	304,715	–	–	0.92%	21
2022 Q4	$2.22M	Hold	304,715	–	–	0.48%	30
2022 Q3	$2.11M	Hold	304,715	–	–	0.49%	35
2022 Q2	$2.13M	Buy	304,715 +25,000	+9%	+$195K	0.57%	33
2022 Q1	$2.31M	Buy	+279,715	New	+$2.52M	0.58%	36

Samsara BioCapital's AMYT Position: Q2 2023 in Review

Samsara BioCapital sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 304,715 shares — an estimated $4.44M sold.

Samsara BioCapital first reported a position in AMYT in Q1 2022 and held it in 5 quarters. The position peaked at $4.44M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Samsara BioCapital reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Samsara BioCapital sold 304,715 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $4.44M.
Samsara BioCapital first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2022 and held it in 5 quarters.
Samsara BioCapital's Amryt Pharma plc American Depositary Shares position peaked at $4.44M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Samsara BioCapital's 13F filing for Q2 2023, filed 14 Aug 2023.